1. Home
  2. CRAI vs IOVA Comparison

CRAI vs IOVA Comparison

Compare CRAI & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

N/A

Current Price

$156.96

Market Cap

1.1B

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$3.79

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRAI
IOVA
Founded
1965
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1998
2008

Fundamental Metrics

Financial Performance
Metric
CRAI
IOVA
Price
$156.96
$3.79
Analyst Decision
Buy
Buy
Analyst Count
1
12
Target Price
$245.00
$10.45
AVG Volume (30 Days)
116.7K
9.3M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
1.44%
N/A
EPS Growth
25.05
32.28
EPS
6.74
N/A
Revenue
$687,414,000.00
N/A
Revenue This Year
$10.57
$60.04
Revenue Next Year
$3.66
$58.54
P/E Ratio
$23.81
N/A
Revenue Growth
10.17
N/A
52 Week Low
$149.96
$1.64
52 Week High
$227.29
$5.64

Technical Indicators

Market Signals
Indicator
CRAI
IOVA
Relative Strength Index (RSI) 35.32 77.86
Support Level $149.96 $2.11
Resistance Level $195.52 $3.73
Average True Range (ATR) 8.58 0.19
MACD -0.50 0.09
Stochastic Oscillator 24.34 97.56

Price Performance

Historical Comparison
CRAI
IOVA

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: